Search Orphan Drug Designations and Approvals
-
Generic Name: | Aloxistatin |
---|---|
Date Designated: | 05/10/2022 |
Orphan Designation: | Treatment of GM1-gangliosidosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
DORPHAN SA Chemin de l’Eglise 7 Epalinges, Vaud CH-1066 Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-